Vascular access-related thrombotic complications: Research hypotheses and therapeutic strategies

Journal of Nephrology

Volumn 19, Issue 3, 2006, Pages 280-285

  Bruno, Simona ^a   Remuzzi, G ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; FISH OIL; HEPARINOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; PHOSPHOLIPID ANTIBODY; PLACEBO; POLITEF; STREPTOKINASE; SULFINPYRAZONE; UROKINASE; WARFARIN;

CLINICAL TRIAL; GAMMA RADIATION; GENE THERAPY; HUMAN; INFECTION; LOW DRUG DOSE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; STENOSIS; STENT; THROMBOSIS; VASCULAR ACCESS; VASCULAR PATENCY; ARTERIOVENOUS SHUNT; CENTRAL VENOUS CATHETERIZATION; INDWELLING CATHETER; KIDNEY FAILURE; RENAL REPLACEMENT THERAPY; STENOSIS, OCCLUSION AND OBSTRUCTION; VEIN THROMBOSIS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CONSTRICTION, PATHOLOGIC; HUMANS; RENAL DIALYSIS; RENAL INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 33749077325     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Fan PY, Schwab SJ. Vascular access: Concepts for the 1990s. J Am Soc Nephrol 1992; 3: 1-11.
2. Hakim RM, Himmelfarb J. Haemodialysis access failure: A call to action. Kidney Int 1998; 54: 1029-40.
3. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis. Ann Surg 1985; 202: 235-9.
4. Munda R, First MR, Alexander JW, Linnemann CC Jr, Fidler JP, Kittur D. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249: 219-22.
5. Feldman HI, Kobrin S, Wasserstein A. Haemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-35.
6. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-6.
7. National Kidney Foundation. NKF-DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 2001; 37 (Suppl 1): S137.
8. Windus DW. Permanent vascular access: A nephrologist's view. Am J Kidney Dis 1993; 21: 457-71.
9. Campos RP, Do Nascimento MM, Chula DC, Do Nascimento DE, Riella MC. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int 2006; 10: 152-61.
10. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, Meyer K, Beasley D. Vascular access for hemodialysis. Kidney Int 1999; 55: 2078-90.
11. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared to low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-90.
12. Sands JJ, Nudo SA, Ashford RG, Moore KD, Ortel TL. Antibodies to topical bovine thrombin correlate with access thrombosis. Am J Kidney Dis 2000; 35: 796-801.
13. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989; 80: 1726-36.
14. Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993; 13: 609-17.
15. Sterpetti AV, Cucina A, Santoro L, Cardillo B, Cavallaro A. Modulation of arterial smooth muscle cell growth by hemodynamic forces. Eur J Vasc Surg 1992; 6: 16-20.
16. Hsieh HJ, Li NQ, Frangos JA. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol 1991; 260: H642-6.
17. Hofstra L, Bergmans DC, Hoeks AP, Kitslaar PJ, Leunissen KM, Tordoir JH. Mismatch in elastic properties around anastomoses of interposition grafts for hemodialysis access. J Am Soc Nephrol 1994; 5: 1243-50.
18. Himmelfarb J. Pharmacologic prevention of vascular access stenosis. Curr Opin Nephrol Hypertens 1999; 8: 569-72.
19. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of hemodialysis fistula thrombosis: Early detection of venous stenosis. Kidney Int 1989; 36: 707-11.
20. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 1992; 42: 1390-7.
21. Windus DW, Audrain J, Vanderson R, Jendrisak MD, Picus D, Delmez JA. Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction. Kidney Int 1990; 38: 337-41.
22. Collins DM, Lambert MB, Middleton JP, Proctor RK, Davidson CJ, Newman GE, Schwab SJ. Fistula dysfunction: Effect on rapid hemodialysis. Kidney Int 1992; 41: 1292-6.
23. Haage P, Vorwerk D, Wildberger JE, Piroth W, Schurmann K, Gunther RW. Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int 2000; 57: 1169-75.
24. Gunther RW, Vorwerk D, Bohndorf K, Klose KC, Kistler D, Mann H, Sieberth HG, el-Din A. Venous stenoses in dialysis shunts: Treatment with self-expanding metallic stents. Radiology 1989; 170: 401-5.
25. Beathard G. Gianturco self-expanding stents in the treatment of stenoses in dialysis access grafts. Kidney Int 1993; 43: 872-7.
26. Kovalik E, Newman G, Suhocki P, Knelson M, Schwab SJ. Correction of central venous stenoses: use of angioplasty and vascular Wallstents. Kidney Int 1994; 45: 1177-81.
27. Mickley V, Gorich J, Rilinger N, Storck M, Abendroth D. Stenting of central venous stenoses in hemodialysis patients: long-term results. Kidney Int 1997; 51: 277-80.
28. Haage P, Vorwerk D, Piroth W, Schuermann K, Guenther RW. Treatment of hemodialysis-related central venous stenosis or occlusion: results of primary Wallstent placement and follow-up in 50 patients. Radiology 1999; 212: 175-80.
29. Hurt AV, Batello-Cruz M, Skipper BJ, Teaf SR, Sterling WA Jr. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146: 844-7.
30. Domoto DT, Bauman JE, Joist JH. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991; 62: 737-43.
31. Sreedhara R, Himmelfarb J, Lazarus M, Hakim R. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 1994; 45: 1477-83.
32. Brunet P, Aillaud MF, San Marco M, Philip-Joet C, Dussol B, Bernard D, Juhan-Vague I, Berland Y. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int 1995; 48: 794-800.
33. Prakash R, Miller CC III, Suki WN. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 1995; 26: 347-52.
34. Shemin D, Lapane KL, Bausserman L, Kanaan E, Kahn S, Dworkin L, Bostom AG. Plasma total homocysteine and hemodialysis access thrombosis: a prospective study. J Am Soc Nephrol 1999; 10: 1095-9.
35. Tamura T, Bergman SM, Morgan SL. Homocysteine, B vitamins and vascular access thrombosis in patients treated with haemodialysis. Am J Kidney Dis 1998; 32: 475-81.
36. Sirrs S, Duncan L, Djurdjev O, Nussbaumer G, Ganz G, Frohlich J, Levin A. Homocysteine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738-43.
37. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB 3rd. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis prevention. Circulation 1995; 91: 1533-9.
38. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-703.
39. Wong FK, Kwok PC, Ngan RK, Wong RK, Wong KW, Chan S, Chau KF, Li CS. Prevention of restenosis of central venous stricture after percutaneous transluminal angioplasty and endovascular stenting by bracytherapy. Kidney Int 1999; 55: 742-3.
40. Sukhatme V. Vascular access stenosis: Prospects for prevention and therapy. Kidney Int 1996; 49: 1161-74.
41. Young AT, Hunter DW, Castaneda-Zuniga WR, So SKS, Mercado S, Cardella JF, Amplatz K. Thrombosed synthetic hemodialysis access fistulas: failure of thrombolytic therapy. Radiology 1985; 154: 639-42.
42. Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late results. Radiology 1991; 178: 243-7.
43. Ahmed A, Shapiro WB, Porush JG. The use of tissue plasminogen activator to declot arteriovenous accesses in hemodialysis patients. Am J Kidney Dis 1993; 21: 38-43.
44. Schon D, Mishler R. Salvage of occluded autologous arteriovenous fistulae. Am J Kidney Dis 2000; 36: 804-10.
45. Beathard GA. Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts. J Am Soc Nephrol 1995; 6: 1619-24.
46. Beathard GA. Mechanical versus pharmacological thrombolysis for the treatment of thrombosed dialysis access grafts. Kidney Int 1994; 45: 1401-6.
47. Trerotola SO, Lund GB, Scheel PJ Jr, Savader SJ, Venbrux AC, Osterman FA Jr. Thrombosed dialysis access grafts: percutaneous mechanical declotting without urokinase. Radiology 1994; 191: 721-6.
48. Turmel-Rodrigues L, Pengloan J, Rodrigue H, Brillet G, Lataste A, Pierre D, Jourdan JL, Blanchard D. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int 2000; 57: 1124-40.
49. Sofocleous C, Cooper SI, Schur, Patel RI, Iqbal A, Walker S. Retrospective comparison of the Amplatz Thrombectomy Device with Modified Pulse-Spray Pharmacomechanical Thrombolysis in the treatment of thrombosed haemodialysis vascular access grafts. Radiology 1999; 213: 561-7.
50. Petronis JD, Regan F, Briefel G, Simpson PM, Hess JM, Contoreggi CS. Ventilation-perfusion scintigraphic evaluation of pulmonary clot burden after percutaneous thrombolysis of clotted hemodialysis access grafts. Am J Kidney Dis 1999; 34: 207-11.
51. Newman GE, Saeed M, Himmelstein S, Cohan RH, Schwab SJ. Total central vein obstruction: resolution with angioplasty and fibrinolysis. Kidney Int 1991; 39: 761-4.